Axsome Therapeutics (AXSM) Interest Coverage Ratio Growth (3y) (2018 - 2026)
Axsome Therapeutics (AXSM) Interest Coverage Ratio Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 40.09% |
| 10 | Axsome Therapeutics | 12.26 Bn | 11.95 Bn | 176.48 Mn | -115.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115.01% |
| Dec 31, 2025 | 27.64% |
| Sep 30, 2025 | -62.15% |
| Jun 30, 2025 | -42.98% |
| Mar 31, 2025 | 35.98% |
| Dec 31, 2024 | 35.15% |
| Sep 30, 2024 | -278.30% |
| Jun 30, 2024 | -319.34% |
| Mar 31, 2024 | 24.39% |
| Dec 31, 2023 | 12.59% |
| Sep 30, 2023 | -361.99% |
| Jun 30, 2023 | -430.35% |
| Mar 31, 2023 | 77.32% |
| Dec 31, 2022 | 28.47% |
| Sep 30, 2022 | 10.95% |
| Jun 30, 2022 | -19.98% |
| Mar 31, 2022 | 10.86% |
| Dec 31, 2021 | -36.88% |
| Sep 30, 2021 | 70.85% |
| Jun 30, 2021 | 73.29% |